Evidence map›Paper›PMID 39314457›Full record

ArticlebioRxiv : the preprint server for biology2024

Unveiling the hidden interactome of CRBN molecular glues with chemoproteomics.

Kheewoong Baek, Rebecca J Metivier, Shourya S Roy Burman, Jonathan W Bushman, Hojong Yoon, Ryan J Lumpkin, Dinah M Abeja, Megha Lakshminarayan, Hong Yue, Samuel Ojeda and 4 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Kheewoong BaekDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Rebecca J MetivierDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Shourya S Roy BurmanDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Jonathan W BushmanDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Hojong YoonDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Ryan J LumpkinDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Dinah M AbejaDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Megha LakshminarayanDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Hong YueDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Samuel OjedaDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Alyssa L VeranoDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Nathanael S GrayDepartment of Chemical and Systems Biology, ChEM-H and Stanford Cancer Institute, Stanford Medical School, Stanford University, Stanford, CA, 94305, USA.
Katherine A DonovanDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Eric S FischerDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.

Funding

The molecular basis of IMiD induced neo-substrate recruitment to the CRL4CRBN ubiquitin E3 ligase.R01CA214608 · NCI · DANA-FARBER CANCER INST · PI Eric Sebastian Fischer · 2017 to 2026
$4.0M
Harvard Chemical Biology PhD ProgramT32GM139775 · NIGMS · HARVARD UNIVERSITY · PI Emily Patricia Balskus, PHILIP A COLE · 2022 to 2026
$2.6M
Development of a generalizable chemo-proteomics screening platform for small molecule degraders applied to HDACsR01CA262188 · NCI · DANA-FARBER CANCER INST · PI FISCHER, ERIC SEBASTIAN · 2022 to 2025
$1.8M
NCI NIH HHS R01 CA214608NCI NIH HHS R01 CA262188NIGMS NIH HHS T32 GM139775
6 · The paper itself

Abstract

Targeted protein degradation and induced proximity refer to strategies that leverage the recruitment of proteins to facilitate their modification, regulation or degradation. As prospective design of glues remains challenging, unbiased discovery methods are needed to unveil hidden chemical targets. Here we establish a high throughput affinity purification mass spectrometry workflow in cell lysates for the unbiased identification of molecular glue targets. By mapping the targets of 20 CRBN-binding molecular glues, we identify 298 protein targets and demonstrate the utility of enrichment methods for identifying novel targets overlooked using established methods. We use a computational workflow to estimate target confidence and perform a biochemical screen to identify a lead compound for the new non-ZF target PPIL4. Our study provides a comprehensive inventory of targets chemically recruited to CRBN and delivers a robust and scalable workflow for identifying new drug-induced protein interactions in cell lysates.

Indexed as

cereblondegraderE3 ligaseIMiDmolecular gluePPIL4PROTACproteomicstargeted protein degradationubiquitin

Identifiers

PMID39314457
PMCPMC11419069

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.